THURSDAY, Feb. 8, 2018 -- Two cancer drugs can stall the progression of a particularly hard-to-treat form of prostate cancer, a pair of new trials shows.
Both a newly developed drug called apalutamide and an already approved drug called enzalutamide (Xtandi) kept prostate cancer from spreading for two years in men whose disease had not yet traveled to other parts of their bodies.
FRIDAY, Jan. 26, 2018 -- Obesity and other health problems may boost the chances of cancer returning after a man has his prostate removed, a new study finds.
"Prostate cancer is the most common cancer in men, and up to 30 percent of patients will develop recurrence after [prostate removal]," said study author Dr. Arash Samiei, of Allegheny Health Network's urology department in Pittsburgh.
WEDNESDAY, Jan. 17, 2018 -- Men who are avid cyclists needn't worry that hours spent on the bike will translate into problems in the bedroom or bathroom, new research claims.
Reportedly the largest study of its kind involving bikers, swimmers and runners, the findings buck prior reports that cycling could harm sexual or urinary function due to prolonged pressure on the buttocks and the perineum (the area between the scrotum and the anus).